Objectives: We studied the short- and long-term effects of imatinib in hospitalized COVID-19 patients.
Methods: Participants were randomized to receive standard of care (SoC) or SoC with imatinib. Imatinib dosage was 400 mg daily until discharge (max 14 days).
Aims: In this study, we examined the voluntary COVID-19 vaccine coverage among health care workers (HCWs) working in close patient contact. HCWs' beliefs about COVID-19 infection, their opinions of vaccination and reasons for having or declining the COVID-19 vaccination were also evaluated.
Methods: In October 2021, a cross-sectional observational study was carried out in five hospitals in Central and Eastern Finland.
Objectives: Respiratory syncytial virus (RSV) is one of the most important causes of lower respiratory tract illnesses. In this study, we examined the number and severity of RSV infections among adult patients. The underlying diseases and background information of patients with RSV were examined and compared with the patients with influenza.
View Article and Find Full Text PDFMultidrug-resistant TB (MDR-TB) is a growing problem in the effort to end the global TB epidemic. In 2019, the WHO adopted a new standardised regiment for MDR-TB, consisting of only oral medications. We estimated the impact of the new guidelines on the costs of TB treatment in Estonia and Finland.
View Article and Find Full Text PDFIntroduction: Finland was the first European country to introduce a nation-wide mandatory seasonal influenza vaccination policy for healthcare workers (HCWs) by mandating that administrators of health care institutions only employ vaccinated HCWs. In this study, we examine the effects of the new policy and the view of HCWs on the new policy.
Methods: A cross-sectional observational study was conducted in Kuopio University Hospital among HCWs working in close patient contact.